Financial Advocates Investment Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4
| Closed | -$2K | – | 820 |
|
|
2022
Q2 | $2K | Hold |
4
| – | – | ﹤0.01% | 683 |
|
|
2022
Q1 | $5K | Buy |
+4
| New | +$5K | ﹤0.01% | 725 |
|
|
2021
Q4 | – | Sell |
-4
| Closed | -$12K | – | 803 |
|
|
2021
Q3 | $12K | Hold |
4
| – | – | ﹤0.01% | 736 |
|
|
2021
Q2 | $12K | Hold |
4
| – | – | ﹤0.01% | 717 |
|
|
2021
Q1 | $17K | Hold |
4
| – | – | ﹤0.01% | 728 |
|
|
2020
Q4 | $10K | Hold |
4
| – | – | ﹤0.01% | 709 |
|
|
2020
Q3 | $10K | Hold |
4
| – | – | ﹤0.01% | 615 |
|
|
2020
Q2 | $15K | Hold |
4
| – | – | ﹤0.01% | 585 |
|
|
2020
Q1 | $8K | Hold |
4
| – | – | ﹤0.01% | 470 |
|
|
2019
Q4 | $43K | Sell |
4
-3
| -43% | -$32.3K | ﹤0.01% | 501 |
|
|
2019
Q3 | $119K | Buy |
+7
| New | +$119K | 0.01% | 470 |
|